Company to host public (L)earnings call on August 5th at 8:00 am ET / 6:00 am MT / 1:00 pm BSTSalt Lake City, UT, July 29, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage ...

Given that, it's hardly encouraging that Biodexa has taken a big step forward ahead of Recursion in the development of its ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Discover how self-improving AI systems are redefining innovation, reshaping industries, and challenging our understanding of ...

Professors Juan Tu, Dong Zhang, Jingning Zhu, and Academician Ning Gu from Nanjing University developed an ultrafast ultrasound localization microscopy algorithm combining velocity constraints and ...

AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI's impact in ...

Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering artificial intelligence company transforming oncology drug discovery and development, today announced the public release of its AI module for ...

Building public trust is essential for brands to cut through the noise, and storytelling is one of the most effective ways to do so. We live in an innovation age, and innovation leads to ...

Will AI take over the world? Nobody knows for sure, but we examine the most compelling arguments from both sides of the ...

As AI replaces labor and optimizes life, the real risk isn’t extinction, it’s the loss of meaning, identity, and human purpose in a fully automated world.